Repare Therapeutics IncNASDAQ:RPTX
- LAST PRICE4.0200
- TODAY'S CHANGE (%)0.4900 (13.8810%)
- Bid / Lots4.0200/ 17
- Ask / Lots4.1000/ 9
- Open / Previous Close3.6100 / 3.5300
- Day Range
- 52 Week Range
- Volume561,967
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPTX |
|---|---|---|
| 09:32 ET | 3783 | 3.57 |
| 09:34 ET | 1850 | 3.5607 |
| 09:36 ET | 52729 | 3.675 |
| 09:38 ET | 2200 | 3.5801 |
| 09:39 ET | 2562 | 3.67 |
| 09:41 ET | 6300 | 3.63 |
| 09:43 ET | 200 | 3.63 |
| 09:45 ET | 51600 | 3.63 |
| 09:48 ET | 500 | 3.6596 |
| 09:50 ET | 900 | 3.63 |
| 09:52 ET | 300 | 3.63 |
| 09:54 ET | 300 | 3.62 |
| 09:56 ET | 2438 | 3.66 |
| 09:57 ET | 400 | 3.68 |
| 09:59 ET | 300 | 3.73 |
| 10:01 ET | 3692 | 3.82 |
| 10:03 ET | 4580 | 3.805 |
| 10:06 ET | 3791 | 3.7522 |
| 10:08 ET | 1141 | 3.75 |
| 10:10 ET | 3090 | 3.758 |
| 10:12 ET | 1750 | 3.7575 |
| 10:14 ET | 100 | 3.73 |
| 10:19 ET | 100 | 3.75 |
| 10:21 ET | 100 | 3.71 |
| 10:24 ET | 5850 | 3.81 |
| 10:26 ET | 13463 | 3.8504 |
| 10:28 ET | 155 | 3.85 |
| 10:30 ET | 3447 | 3.8414 |
| 10:33 ET | 2444 | 3.85 |
| 10:35 ET | 1041 | 3.88 |
| 10:37 ET | 9060 | 3.9386 |
| 10:39 ET | 1210 | 3.915 |
| 10:42 ET | 4845 | 3.89 |
| 10:44 ET | 6898 | 3.88 |
| 10:46 ET | 1490 | 3.89 |
| 10:48 ET | 1544 | 3.89 |
| 10:50 ET | 1600 | 3.9 |
| 10:51 ET | 1059 | 3.8801 |
| 10:53 ET | 2200 | 3.865 |
| 10:55 ET | 500 | 3.865 |
| 10:57 ET | 4456 | 3.83 |
| 11:00 ET | 1803 | 3.86 |
| 11:02 ET | 400 | 3.875 |
| 11:04 ET | 650 | 3.868 |
| 11:08 ET | 500 | 3.899 |
| 11:09 ET | 1968 | 3.92 |
| 11:11 ET | 2616 | 3.95 |
| 11:13 ET | 5261 | 3.96 |
| 11:15 ET | 250 | 3.96 |
| 11:20 ET | 799 | 3.9 |
| 11:22 ET | 1498 | 3.9 |
| 11:24 ET | 504 | 3.9 |
| 11:26 ET | 6128 | 3.9299 |
| 11:27 ET | 600 | 3.8905 |
| 11:29 ET | 500 | 3.895 |
| 11:31 ET | 238 | 3.885 |
| 11:33 ET | 600 | 3.885 |
| 11:36 ET | 100 | 3.91 |
| 11:38 ET | 1000 | 3.9099 |
| 11:40 ET | 6120 | 3.905 |
| 11:42 ET | 200 | 3.91 |
| 11:44 ET | 3943 | 3.9 |
| 11:47 ET | 162 | 3.91 |
| 11:49 ET | 200 | 3.9 |
| 11:54 ET | 2225 | 3.9299 |
| 11:56 ET | 509 | 3.93 |
| 11:58 ET | 5244 | 3.955 |
| 12:00 ET | 1327 | 3.97 |
| 12:02 ET | 597 | 3.96 |
| 12:03 ET | 300 | 3.96 |
| 12:05 ET | 800 | 3.95 |
| 12:07 ET | 464 | 3.9488 |
| 12:09 ET | 838 | 3.95 |
| 12:12 ET | 4497 | 4 |
| 12:14 ET | 2581 | 3.99 |
| 12:16 ET | 300 | 3.98 |
| 12:18 ET | 300 | 3.9999 |
| 12:20 ET | 18568 | 3.93 |
| 12:21 ET | 3345 | 3.92 |
| 12:23 ET | 261 | 3.9486 |
| 12:25 ET | 1300 | 3.95 |
| 12:27 ET | 400 | 3.95 |
| 12:30 ET | 900 | 3.95 |
| 12:34 ET | 200 | 3.95 |
| 12:36 ET | 1717 | 3.9848 |
| 12:38 ET | 100 | 3.97 |
| 12:41 ET | 216 | 3.9799 |
| 12:50 ET | 127 | 3.96 |
| 12:54 ET | 740 | 3.95 |
| 12:57 ET | 400 | 3.9495 |
| 12:59 ET | 400 | 3.95 |
| 01:01 ET | 1100 | 3.9401 |
| 01:03 ET | 500 | 3.9591 |
| 01:06 ET | 250 | 3.9686 |
| 01:08 ET | 117 | 3.9686 |
| 01:17 ET | 600 | 3.965 |
| 01:19 ET | 1200 | 3.9724 |
| 01:24 ET | 211 | 3.9518 |
| 01:26 ET | 300 | 3.96 |
| 01:28 ET | 1386 | 3.95 |
| 01:30 ET | 100 | 3.97 |
| 01:32 ET | 1100 | 3.97 |
| 01:35 ET | 600 | 3.9686 |
| 01:37 ET | 4300 | 3.945 |
| 01:44 ET | 100 | 3.94 |
| 01:46 ET | 200 | 3.94 |
| 01:48 ET | 1950 | 3.9458 |
| 01:53 ET | 600 | 3.9486 |
| 01:55 ET | 4000 | 3.93 |
| 01:57 ET | 3674 | 3.81 |
| 02:00 ET | 1694 | 3.8 |
| 02:02 ET | 1159 | 3.8 |
| 02:04 ET | 1000 | 3.83 |
| 02:06 ET | 1685 | 3.86 |
| 02:08 ET | 100 | 3.86 |
| 02:11 ET | 500 | 3.87 |
| 02:15 ET | 200 | 3.85 |
| 02:22 ET | 790 | 3.855 |
| 02:24 ET | 8340 | 3.96 |
| 02:26 ET | 400 | 3.95 |
| 02:27 ET | 102081 | 3.975 |
| 02:29 ET | 225 | 4 |
| 02:33 ET | 216 | 3.9999 |
| 02:38 ET | 150 | 3.95 |
| 02:42 ET | 100 | 3.99 |
| 02:45 ET | 600 | 3.95 |
| 02:49 ET | 125 | 3.9744 |
| 02:51 ET | 2903 | 3.98 |
| 02:54 ET | 100 | 3.95 |
| 02:56 ET | 247 | 3.95 |
| 03:03 ET | 300 | 3.98 |
| 03:05 ET | 5000 | 4 |
| 03:07 ET | 12295 | 4.02 |
| 03:09 ET | 2384 | 4.06 |
| 03:12 ET | 1600 | 4.04 |
| 03:14 ET | 200 | 4.03 |
| 03:16 ET | 680 | 4.04 |
| 03:18 ET | 630 | 4.06 |
| 03:20 ET | 300 | 4.0415 |
| 03:21 ET | 1800 | 4.0515 |
| 03:23 ET | 100 | 4.0504 |
| 03:25 ET | 5934 | 4.09 |
| 03:27 ET | 300 | 4.1003 |
| 03:30 ET | 713 | 4.11 |
| 03:34 ET | 3811 | 4.0509 |
| 03:36 ET | 6537 | 4.04 |
| 03:38 ET | 1989 | 4.04 |
| 03:39 ET | 300 | 4.035 |
| 03:41 ET | 100 | 4.04 |
| 03:43 ET | 368 | 4.04 |
| 03:45 ET | 643 | 4.035 |
| 03:48 ET | 501 | 4.01 |
| 03:50 ET | 100 | 4.02 |
| 03:52 ET | 349 | 4.005 |
| 03:54 ET | 8906 | 4.065 |
| 03:56 ET | 1332 | 4.0699 |
| 03:57 ET | 8750 | 4.0796 |
| 03:59 ET | 18375 | 4.02 |
Today
Yesterday
Jun 3, 2024
Repare Therapeutics to Participate in the Goldman Sachs 45(th) Annual Global Healthcare Conference, from 4:05PM ET on Monday Jun 03, 2024 by Dow Jones
4:05PM ET on Monday Jun 03, 2024 by Dow Jones
May 29, 2024
Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024, from 7:05AM ET on Wednesday May 29, 2024 by Dow Jones
7:05AM ET on Wednesday May 29, 2024 by Dow Jones
May 8, 2024
DJ Repare Therapeutics Shares Rise 17% After 1Q Earnings, Revenue Beats, from 12:34PM ET on Wednesday May 08, 2024 by Dow Jones
12:34PM ET on Wednesday May 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Repare Therapeutics Inc | 147.7M | -3.7x | --- |
Precision BioSciences Inc | 89.3M | -2.4x | --- |
Champions Oncology Inc | 61.6M | -6.4x | --- |
AVITA Medical Inc | 247.9M | -5.4x | --- |
Metagenomi Inc | 239.0M | -3.6x | --- |
MEI Pharma Inc | 19.1M | 0.7x | --- |
Company Information
Repare Therapeutics Inc. is a clinical-stage precision oncology company focused on the development of synthetic lethality (SL)-based therapies for patients with cancer. The Company is engaged in the proprietary SL approach to the discovery and development of novel therapeutics. It uses its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies focused on genomic instability, including deoxyribonucleic acid (DNA) damage repair. The Company’s initial product candidate, camonsertib (RP-3500 or RG6526), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase (ATR) for the treatment of solid tumors with specific DNA damage repair-related genomic alterations, including those in the ataxia telangiectasia mutated kinase (ATM) gene as part of a network of 16 STEP2-identified genomic alterations. Its other pipeline includes Lunresertib PKMYT1 Inhibitor and RP-3467 polymerase theta (Pol0) Inhibitor.
Contact Information
- Headquarters
- 7210 Frederick-Banting, Suite 100ST-LAURENT, QC, Canada H4S 2A1
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Thomas Civik
- President, Chief Executive Officer, Director
- Lloyd Segal
- Chief Financial Officer, Executive Vice President
- Steve Forte
- Executive Vice President, Chief Scientific Officer
- Michael Zinda
- Executive Vice President, Chief Medical Officer
- Maria Koehler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $147.7M |
|---|---|
Revenue (TTM) | $97.9M |
Shares Outstanding | 42.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.73 |
EPS | $-1.10 |
Book Value | $5.03 |
P/E Ratio | -3.7x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -72.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
